nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—CHUK—connective tissue—salivary gland cancer	0.0162	0.0968	CbGeAlD
Mesalazine—CHUK—epithelium—salivary gland cancer	0.0153	0.0919	CbGeAlD
Mesalazine—CHUK—lymphoid tissue—salivary gland cancer	0.0118	0.0708	CbGeAlD
Mesalazine—IKBKB—connective tissue—salivary gland cancer	0.011	0.0658	CbGeAlD
Mesalazine—PPARG—neck—salivary gland cancer	0.00954	0.0571	CbGeAlD
Mesalazine—ALOX5—connective tissue—salivary gland cancer	0.0091	0.0545	CbGeAlD
Mesalazine—IKBKB—lymphoid tissue—salivary gland cancer	0.00803	0.0481	CbGeAlD
Mesalazine—MPO—connective tissue—salivary gland cancer	0.0077	0.0461	CbGeAlD
Mesalazine—MPO—epithelium—salivary gland cancer	0.00731	0.0438	CbGeAlD
Mesalazine—PPARG—connective tissue—salivary gland cancer	0.00683	0.0409	CbGeAlD
Mesalazine—CHUK—lymph node—salivary gland cancer	0.00667	0.0399	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—salivary gland cancer	0.00666	0.0399	CbGeAlD
Mesalazine—PPARG—epithelium—salivary gland cancer	0.00649	0.0389	CbGeAlD
Mesalazine—MPO—lymphoid tissue—salivary gland cancer	0.00563	0.0337	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—salivary gland cancer	0.005	0.0299	CbGeAlD
Mesalazine—IKBKB—lymph node—salivary gland cancer	0.00453	0.0271	CbGeAlD
Mesalazine—ALOX5—lymph node—salivary gland cancer	0.00376	0.0225	CbGeAlD
Mesalazine—PTGS1—connective tissue—salivary gland cancer	0.00365	0.0219	CbGeAlD
Mesalazine—PTGS2—connective tissue—salivary gland cancer	0.00349	0.0209	CbGeAlD
Mesalazine—PTGS1—epithelium—salivary gland cancer	0.00347	0.0208	CbGeAlD
Mesalazine—PTGS2—epithelium—salivary gland cancer	0.00332	0.0199	CbGeAlD
Mesalazine—MPO—lymph node—salivary gland cancer	0.00318	0.019	CbGeAlD
Mesalazine—PPARG—lymph node—salivary gland cancer	0.00282	0.0169	CbGeAlD
Mesalazine—PTGS2—lymphoid tissue—salivary gland cancer	0.00255	0.0153	CbGeAlD
Mesalazine—PTGS1—lymph node—salivary gland cancer	0.00151	0.00903	CbGeAlD
Mesalazine—PTGS2—lymph node—salivary gland cancer	0.00144	0.00863	CbGeAlD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	0.000386	0.000464	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAML3—salivary gland cancer	0.000386	0.000463	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGF16—salivary gland cancer	0.000385	0.000462	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CCND1—salivary gland cancer	0.000383	0.00046	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AQP1—salivary gland cancer	0.000383	0.00046	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL17RD—salivary gland cancer	0.000383	0.000459	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000382	0.000459	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CYLD—salivary gland cancer	0.000381	0.000458	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—PTEN—salivary gland cancer	0.000379	0.000455	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PYGB—salivary gland cancer	0.000377	0.000452	CbGpPWpGaD
Mesalazine—PTGS2—Disease—WNT5B—salivary gland cancer	0.00037	0.000444	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NUP62—salivary gland cancer	0.000369	0.000443	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—FOXO3—salivary gland cancer	0.000367	0.000441	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PRKDC—salivary gland cancer	0.000366	0.000439	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000365	0.000439	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.00036	0.000432	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL17RD—salivary gland cancer	0.000357	0.000429	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CPSF4—salivary gland cancer	0.000357	0.000429	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PYGB—salivary gland cancer	0.000357	0.000429	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGF16—salivary gland cancer	0.000355	0.000426	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MAML2—salivary gland cancer	0.000354	0.000425	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000353	0.000424	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—FOXO3—salivary gland cancer	0.000353	0.000423	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000352	0.000423	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	0.00035	0.000421	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAML3—salivary gland cancer	0.00035	0.00042	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.00035	0.00042	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGF16—salivary gland cancer	0.000349	0.000419	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—HRAS—salivary gland cancer	0.000347	0.000417	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000347	0.000417	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MC3R—salivary gland cancer	0.000344	0.000413	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000344	0.000412	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000342	0.00041	CbGpPWpGaD
Mesalazine—CHUK—Disease—NUP62—salivary gland cancer	0.000341	0.000409	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.00034	0.000408	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—PIK3CA—salivary gland cancer	0.000338	0.000406	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000338	0.000406	CbGpPWpGaD
Mesalazine—CHUK—Disease—VCAN—salivary gland cancer	0.000338	0.000406	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NUP62—salivary gland cancer	0.000334	0.000401	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000334	0.0004	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—HRAS—salivary gland cancer	0.000333	0.000399	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000331	0.000398	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MAP2K2—salivary gland cancer	0.000331	0.000397	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SMC1A—salivary gland cancer	0.000327	0.000393	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—NOTCH1—salivary gland cancer	0.000327	0.000392	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAML3—salivary gland cancer	0.000327	0.000392	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MARCKS—salivary gland cancer	0.000322	0.000386	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000318	0.000382	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—PIK3CA—salivary gland cancer	0.000318	0.000382	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000318	0.000382	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—HRAS—salivary gland cancer	0.000318	0.000381	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.000317	0.00038	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—HRAS—salivary gland cancer	0.000316	0.00038	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000316	0.000379	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—HRAS—salivary gland cancer	0.000315	0.000378	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—HRAS—salivary gland cancer	0.000315	0.000378	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000315	0.000378	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—HRAS—salivary gland cancer	0.000313	0.000376	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—PIK3CA—salivary gland cancer	0.000313	0.000376	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000313	0.000375	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MC3R—salivary gland cancer	0.000312	0.000374	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000311	0.000374	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000309	0.00037	CbGpPWpGaD
Mesalazine—CHUK—Disease—MAML2—salivary gland cancer	0.000309	0.00037	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—PTEN—salivary gland cancer	0.000307	0.000369	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PHGDH—salivary gland cancer	0.000307	0.000369	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000305	0.000366	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NUP62—salivary gland cancer	0.000304	0.000365	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000302	0.000363	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—VCAN—salivary gland cancer	0.000301	0.000362	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DTX4—salivary gland cancer	0.000301	0.000361	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ST3GAL4—salivary gland cancer	0.0003	0.00036	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MAP2K2—salivary gland cancer	0.0003	0.00036	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.0003	0.00036	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PYGB—salivary gland cancer	0.000299	0.000359	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—salivary gland cancer	0.000296	0.000356	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CREBBP—salivary gland cancer	0.000296	0.000356	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ST3GAL4—salivary gland cancer	0.000296	0.000355	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—PIK3CA—salivary gland cancer	0.000295	0.000354	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HRAS—salivary gland cancer	0.000295	0.000354	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000295	0.000354	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000295	0.000354	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—HRAS—salivary gland cancer	0.000292	0.00035	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000291	0.00035	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000291	0.000349	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00029	0.000348	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—HRAS—salivary gland cancer	0.00029	0.000348	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000289	0.000347	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000289	0.000347	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—HRAS—salivary gland cancer	0.000288	0.000346	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGFR4—salivary gland cancer	0.000284	0.000341	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000282	0.000339	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.00028	0.000336	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.00028	0.000336	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FBXW7—salivary gland cancer	0.00028	0.000336	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—PTEN—salivary gland cancer	0.000279	0.000335	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DTX4—salivary gland cancer	0.000273	0.000327	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—HRAS—salivary gland cancer	0.000273	0.000327	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AQP1—salivary gland cancer	0.000268	0.000322	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—PIK3CA—salivary gland cancer	0.000267	0.000321	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000267	0.000321	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000265	0.000318	CbGpPWpGaD
Mesalazine—CHUK—Disease—JAG1—salivary gland cancer	0.000263	0.000316	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGFR4—salivary gland cancer	0.000262	0.000315	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000261	0.000313	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000261	0.000313	CbGpPWpGaD
Mesalazine—CHUK—Disease—FBXW7—salivary gland cancer	0.000258	0.00031	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGFR4—salivary gland cancer	0.000258	0.000309	CbGpPWpGaD
Mesalazine—PTGS2—Disease—DTX4—salivary gland cancer	0.000254	0.000305	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FBXW7—salivary gland cancer	0.000253	0.000304	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.000252	0.000303	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000252	0.000302	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF16—salivary gland cancer	0.000249	0.000299	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—HRAS—salivary gland cancer	0.000247	0.000297	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CREBBP—salivary gland cancer	0.000246	0.000295	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000244	0.000293	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00024	0.000288	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FOXO3—salivary gland cancer	0.000236	0.000283	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000235	0.000282	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDH1—salivary gland cancer	0.000234	0.000281	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF16—salivary gland cancer	0.000226	0.000271	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CREBBP—salivary gland cancer	0.000223	0.000267	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000221	0.000265	CbGpPWpGaD
Mesalazine—CHUK—Disease—FOXO3—salivary gland cancer	0.000218	0.000261	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—PIK3CA—salivary gland cancer	0.000217	0.00026	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAML2—salivary gland cancer	0.000216	0.000259	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000215	0.000258	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FOXO3—salivary gland cancer	0.000214	0.000257	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000213	0.000256	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NUP62—salivary gland cancer	0.000213	0.000255	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDH1—salivary gland cancer	0.000212	0.000255	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—VCAN—salivary gland cancer	0.000211	0.000253	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF16—salivary gland cancer	0.00021	0.000253	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000204	0.000245	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NUP62—salivary gland cancer	0.000202	0.000242	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EP300—salivary gland cancer	0.000202	0.000242	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—HRAS—salivary gland cancer	0.000201	0.000241	CbGpPWpGaD
Mesalazine—PTGS2—Disease—VCAN—salivary gland cancer	0.0002	0.00024	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.0002	0.00024	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—PIK3CA—salivary gland cancer	0.000197	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAML2—salivary gland cancer	0.000196	0.000235	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MAP2K2—salivary gland cancer	0.000193	0.000231	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CREBBP—salivary gland cancer	0.00019	0.000228	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000189	0.000227	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000185	0.000222	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000185	0.000222	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—JAG1—salivary gland cancer	0.000184	0.000221	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGFR4—salivary gland cancer	0.000184	0.000221	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAML2—salivary gland cancer	0.000183	0.000219	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—HRAS—salivary gland cancer	0.000182	0.000218	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FBXW7—salivary gland cancer	0.000181	0.000217	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00018	0.000216	CbGpPWpGaD
Mesalazine—CHUK—Disease—MAP2K2—salivary gland cancer	0.000178	0.000213	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000177	0.000213	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PTEN—salivary gland cancer	0.000175	0.000211	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MAP2K2—salivary gland cancer	0.000175	0.00021	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000172	0.000206	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NUP62—salivary gland cancer	0.000169	0.000203	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PTEN—salivary gland cancer	0.000168	0.000202	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—VCAN—salivary gland cancer	0.000168	0.000201	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—JAG1—salivary gland cancer	0.000167	0.000201	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EP300—salivary gland cancer	0.000167	0.000201	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NOTCH1—salivary gland cancer	0.000167	0.000201	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGFR4—salivary gland cancer	0.000167	0.0002	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FBXW7—salivary gland cancer	0.000164	0.000197	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PTEN—salivary gland cancer	0.000159	0.000191	CbGpPWpGaD
Mesalazine—PTGS2—Disease—JAG1—salivary gland cancer	0.000156	0.000187	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGFR4—salivary gland cancer	0.000155	0.000187	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FBXW7—salivary gland cancer	0.000153	0.000184	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PTEN—salivary gland cancer	0.000153	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FOXO3—salivary gland cancer	0.000152	0.000183	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EP300—salivary gland cancer	0.000152	0.000182	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CREBBP—salivary gland cancer	0.000152	0.000182	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000147	0.000177	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOTCH1—salivary gland cancer	0.000146	0.000175	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CREBBP—salivary gland cancer	0.000143	0.000172	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDH1—salivary gland cancer	0.000142	0.00017	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FOXO3—salivary gland cancer	0.000138	0.000166	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HRAS—salivary gland cancer	0.000138	0.000166	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTEN—salivary gland cancer	0.000136	0.000163	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000133	0.00016	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000132	0.000159	CbGpPWpGaD
Mesalazine—CHUK—Disease—CREBBP—salivary gland cancer	0.000132	0.000159	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CREBBP—salivary gland cancer	0.00013	0.000156	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—EP300—salivary gland cancer	0.00013	0.000156	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FOXO3—salivary gland cancer	0.000129	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDH1—salivary gland cancer	0.000129	0.000155	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000126	0.000151	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAP2K2—salivary gland cancer	0.000124	0.000149	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PIK3CA—salivary gland cancer	0.000124	0.000149	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000119	0.000143	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CREBBP—salivary gland cancer	0.000118	0.000141	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HRAS—salivary gland cancer	0.000114	0.000137	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAP2K2—salivary gland cancer	0.000113	0.000135	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PIK3CA—salivary gland cancer	0.000112	0.000135	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HRAS—salivary gland cancer	0.00011	0.000132	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000108	0.000129	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAP2K2—salivary gland cancer	0.000105	0.000126	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000105	0.000126	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HRAS—salivary gland cancer	0.000104	0.000125	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTEN—salivary gland cancer	0.000102	0.000123	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOTCH1—salivary gland cancer	0.000102	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.0001	0.00012	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HRAS—salivary gland cancer	9.97e-05	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EP300—salivary gland cancer	9.74e-05	0.000117	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PIK3CA—salivary gland cancer	9.59e-05	0.000115	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTEN—salivary gland cancer	9.43e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.34e-05	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTEN—salivary gland cancer	9.26e-05	0.000111	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOTCH1—salivary gland cancer	9.25e-05	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CREBBP—salivary gland cancer	9.25e-05	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Disease—EP300—salivary gland cancer	8.99e-05	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EP300—salivary gland cancer	8.83e-05	0.000106	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOTCH1—salivary gland cancer	8.63e-05	0.000104	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTEN—salivary gland cancer	8.41e-05	0.000101	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CREBBP—salivary gland cancer	8.39e-05	0.000101	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CREBBP—salivary gland cancer	8.25e-05	9.91e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—EP300—salivary gland cancer	8.02e-05	9.63e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CREBBP—salivary gland cancer	7.82e-05	9.39e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.41e-05	8.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PIK3CA—salivary gland cancer	7.21e-05	8.65e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCND1—salivary gland cancer	6.84e-05	8.21e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HRAS—salivary gland cancer	6.67e-05	8e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PIK3CA—salivary gland cancer	6.65e-05	7.99e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTEN—salivary gland cancer	6.6e-05	7.93e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CREBBP—salivary gland cancer	6.55e-05	7.86e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PIK3CA—salivary gland cancer	6.53e-05	7.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EP300—salivary gland cancer	6.3e-05	7.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCND1—salivary gland cancer	6.2e-05	7.45e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—HRAS—salivary gland cancer	6.16e-05	7.39e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HRAS—salivary gland cancer	6.05e-05	7.26e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTEN—salivary gland cancer	5.99e-05	7.19e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PIK3CA—salivary gland cancer	5.94e-05	7.12e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTEN—salivary gland cancer	5.89e-05	7.07e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EP300—salivary gland cancer	5.71e-05	6.86e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—EP300—salivary gland cancer	5.62e-05	6.75e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PTEN—salivary gland cancer	5.59e-05	6.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EP300—salivary gland cancer	5.33e-05	6.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTEN—salivary gland cancer	4.68e-05	5.62e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PIK3CA—salivary gland cancer	4.66e-05	5.59e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—salivary gland cancer	4.51e-05	5.41e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—EP300—salivary gland cancer	4.46e-05	5.36e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HRAS—salivary gland cancer	4.31e-05	5.17e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PIK3CA—salivary gland cancer	4.22e-05	5.07e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PIK3CA—salivary gland cancer	4.16e-05	4.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—salivary gland cancer	4.09e-05	4.91e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PIK3CA—salivary gland cancer	3.94e-05	4.73e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HRAS—salivary gland cancer	3.91e-05	4.69e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HRAS—salivary gland cancer	3.65e-05	4.38e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PIK3CA—salivary gland cancer	3.3e-05	3.96e-05	CbGpPWpGaD
